Lupin's Nagpur facility receives Establishment Inspection Report

Lupin announced the receipt of the Establishment Inspection Report (EIR) from the USFDA for its Nagpur facility. The facility was inspected by the USFDA between 05 August 2019 and 08 August 2019.

The inspection for the oral solid facility at Nagpur closed without any Form 483 observation. The Nagpur facility is Lupin's largest and most advanced ora l solid dosage faci lity and has maintained a solid track record of compliance.

Powered by Capital Market - Live News